Skip to main content
. Author manuscript; available in PMC: 2017 Dec 14.
Published in final edited form as: Restor Neurol Neurosci. 2017;35(6):631–642. doi: 10.3233/RNN-170757

Table 2.

Adverse event description

Description Subjects Severity Times
experienced
Action
taken
Attribution Expected
Tingling sensation 5/5 mild At each session None Definite Yes
Poor sleep 1/5 mild once None Possible No
Perception of continuing stimulation 1/5 mild once None Probable Yes
Headache 1/5 mild once None Possible No
Skin irritation 2/5 mild Three sessions None Probable Yes